Skip to content

CHELSEA THERAPEUTICS INTERNATIONAL, LTD.: 10-K filed 2013-03-07

What CHELSEA THERAPEUTICS INTERNATIONAL, LTD. reported in its annual report filed 2013-03-07 (fiscal FY 2012): 29 published measures, 113 facts as tagged in accession 0001144204-13-013609.

This filing

Form
10-K (annual report)
Filed
2013-03-07
Fiscal period
fiscal FY 2012
Accession
0001144204-13-013609 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHELSEA THERAPEUTICS INTERNATIONAL, LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3128,927,548USD
At 2011-12-3146,902,705USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-313,011,398USD
At 2011-12-3113,237,895USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3125,916,150USD
At 2011-12-3133,664,810USD
At 2010-12-3135,187,764USD
At 2009-12-3112,851,906USD
At 2008-12-3124,547,897USD
At 2007-12-3157,966,579USD
At 2006-12-3114,136,556USD
At 2005-12-312,384,404USD
At 2004-12-3110,541,214USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3128,424,631USD
At 2011-12-3141,106,301USD
At 2010-12-3147,593,055USD
At 2009-12-3122,294,649USD
At 2002-04-020USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-31,735,909USD366
2002-04-03 to 2012-12-31-215,061,410USD3926
2011-01-01 to 2011-12-31-50,452,165USD365
2010-01-01 to 2010-12-31-37,330,069USD365
2009-01-01 to 2009-12-31-25,771,914USD365
2008-01-01 to 2008-12-31-35,086,151USD366
2007-01-01 to 2007-12-31-15,081,545USD365
2006-01-01 to 2006-12-31-8,671,376USD365
2005-01-01 to 2005-12-31-7,915,722USD365
2004-01-01 to 2004-12-31-3,016,559USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-39,365,952USD366
2002-04-03 to 2012-12-31-199,967,451USD3926
2011-01-01 to 2011-12-31-48,039,584USD365
2010-01-01 to 2010-12-31-32,251,773USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-3125,260USD366
2002-04-03 to 2012-12-31739,732USD3926
2011-01-01 to 2011-12-31227,468USD365
2010-01-01 to 2010-12-31151,836USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-3122,159,045USD366
2002-04-03 to 2012-12-31229,115,907USD3926
2011-01-01 to 2011-12-3146,280,470USD365
2010-01-01 to 2010-12-3146,213,160USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,525,237USD366
2002-04-03 to 2012-12-31-723,825USD3926
2011-01-01 to 2011-12-31-4,727,640USD365
2010-01-01 to 2010-12-3111,337,019USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-31151,544USD
At 2011-12-31291,024USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,828,204USD366
2002-04-03 to 2012-12-3110,818,860USD3926
2011-01-01 to 2011-12-312,648,741USD365
2010-01-01 to 2010-12-311,986,755USD365
2009-01-01 to 2009-12-311,673,165USD365
2008-01-01 to 2008-12-311,405,752USD366
2007-01-01 to 2007-12-31828,626USD365
2006-01-01 to 2006-12-31283,983USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-31,803,503USD366
2002-04-03 to 2012-12-31-219,812,175USD3926
2011-01-01 to 2011-12-31-50,613,993USD365
2010-01-01 to 2010-12-31-37,502,563USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3128,776,004USD
At 2011-12-3146,573,414USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2002-04-03 to 2012-12-31258,348USD3926
2011-01-01 to 2011-12-310USD365
2010-01-01 to 2010-12-3170,389USD365

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31788,073USD
At 2011-12-314,866,356USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-3131,803,503USD366
2002-04-03 to 2012-12-31219,812,175USD3926
2011-01-01 to 2011-12-3150,613,993USD365
2010-01-01 to 2010-12-3137,502,563USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-3116,744,423USD366
2002-04-03 to 2012-12-31162,504,846USD3926
2011-01-01 to 2011-12-3137,270,138USD365
2010-01-01 to 2010-12-3130,871,125USD365
2007-01-01 to 2007-12-31600,000USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3167,075,779shares
At 2011-12-3162,034,146shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-31240,970,852USD
At 2011-12-31216,984,108USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-31629,037USD
At 2011-12-31683,233USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-31477,493USD
At 2011-12-31392,209USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-3138,267USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-31496,901USD
At 2011-12-315,245,339USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31176,181USD
At 2011-12-31793,521USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,679,485USD366
2002-04-03 to 2012-12-3130,903,158USD3926
2011-01-01 to 2011-12-315,276,146USD365
2010-01-01 to 2010-12-314,154,944USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-31127,350USD366
2002-04-03 to 2012-12-31549,330USD3926
2011-01-01 to 2011-12-31116,465USD365
2010-01-01 to 2010-12-3175,610USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2002-04-03 to 2012-12-31224,328USD3926
2011-01-01 to 2011-12-310USD365
2010-01-01 to 2010-12-3170,389USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-01-3123,700,000USD31
2011-02-01 to 2011-02-2840,300,000USD28
2010-10-01 to 2010-10-3140,300,000USD31
2010-09-01 to 2010-09-302,900,000USD30
2010-03-01 to 2010-03-3118,200,000USD31
2009-07-01 to 2009-07-3113,300,000USD31
2007-11-01 to 2007-11-3048,900,000USD30
2007-03-01 to 2007-03-3112,500,000USD31
2006-01-01 to 2006-12-3121,500,000USD365
2004-01-01 to 2004-12-3114,500,000USD366

Inspect the source

Entity
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. / CIK 0001333763
Captured
SEC response SHA-256
354bb9243ece9eacb7fe265090cbbf659edca4a013cc87523793af082dfdb51c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001333763.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))